Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Intrinsic Value
The intrinsic value of one Sichuan Biokin Pharmaceutical Co Ltd stock under the Base Case scenario is 12.11 CNY. Compared to the current market price of 283.88 CNY, Sichuan Biokin Pharmaceutical Co Ltd is Overvalued by 96%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Sichuan Biokin Pharmaceutical Co Ltd
Loading...
Fundamental Analysis

Revenue & Expenses Breakdown
Sichuan Biokin Pharmaceutical Co Ltd
Balance Sheet Decomposition
Sichuan Biokin Pharmaceutical Co Ltd
Current Assets | 6.3B |
Cash & Short-Term Investments | 5.8B |
Receivables | 255m |
Other Current Assets | 299.1m |
Non-Current Assets | 830.2m |
Long-Term Investments | 1.3m |
PP&E | 573.1m |
Intangibles | 26.7m |
Other Non-Current Assets | 229m |
Free Cash Flow Analysis
Sichuan Biokin Pharmaceutical Co Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Sichuan Biokin Pharmaceutical Co Ltd
Revenue
|
428m
CNY
|
Cost of Revenue
|
-248.7m
CNY
|
Gross Profit
|
179.3m
CNY
|
Operating Expenses
|
-2.1B
CNY
|
Operating Income
|
-1.9B
CNY
|
Other Expenses
|
86m
CNY
|
Net Income
|
-1.8B
CNY
|
Profitability Score
Profitability Due Diligence
Sichuan Biokin Pharmaceutical Co Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
Score
Sichuan Biokin Pharmaceutical Co Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Sichuan Biokin Pharmaceutical Co Ltd's solvency score is 76/100. The higher the solvency score, the more solvent the company is.
Score
Sichuan Biokin Pharmaceutical Co Ltd's solvency score is 76/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Sichuan Biokin Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Sichuan Biokin Pharmaceutical Co Ltd is 310.58 CNY with a low forecast of 302.39 CNY and a high forecast of 330.4 CNY.
Dividends
Current shareholder yield for Sichuan Biokin Pharmaceutical Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one Sichuan Biokin Pharmaceutical Co Ltd stock under the Base Case scenario is 12.11 CNY.
Compared to the current market price of 283.88 CNY, Sichuan Biokin Pharmaceutical Co Ltd is Overvalued by 96%.